Targeting of Smoothened for therapeutic gain.

Trends Pharmacol Sci

Laboratoire d'Innovation Thérapeutique, UMR 7200, MEDALIS Drug Discovery Center, 74 route du Rhin, 67400 Illkirch, France.

Published: May 2014

AI Article Synopsis

  • The Smoothened (Smo) receptor is essential for the Hedgehog (Hh) signaling pathway, crucial for tissue maintenance and repair.
  • Recent research emphasizes the potential of Smo antagonists as treatments for cancers associated with Hh signaling.
  • This review discusses the therapeutic significance of Smo modulators and the complexities of their pharmacology in clinical settings.

Article Abstract

The Smoothened (Smo) receptor is a key transducer of the Hedgehog (Hh) signaling pathway, which plays a critical role in tissue maintenance and repair. Recent studies have highlighted the therapeutic value of Smo antagonists for treating Hh-linked cancers. Research on Smo agonists indicates that these molecules are important not only for delineating canonical versus noncanonical Hh signaling but also for understanding the role of Smo in physiological and pathological conditions. This review provides an update on the potential therapeutic importance of Smo modulators, and unravels the increasing complexity of its pharmacology with regard to clinical implications.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tips.2014.03.002DOI Listing

Publication Analysis

Top Keywords

therapeutic smo
8
smo
5
targeting smoothened
4
smoothened therapeutic
4
therapeutic gain
4
gain smoothened
4
smoothened smo
4
smo receptor
4
receptor key
4
key transducer
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!